Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imran Ahmad

Showing results (421-430 of 442) with videos related to

Pageof 45
Sort By:
European Urology Open Science|August 2, 2021
Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal MetastasisChara Ntala, Mark Salji, Jonathan Salmond, et al.
BJU International|December 8, 2021
Feasibility and safety of radical prostatectomy for oligo-metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo-Metastases to the bone (TRoMbone) trialPrasanna Sooriakumaran, Caroline Wilson, Ines Rombach, et al.
Cancer Research|November 14, 2019
Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate CancerRachana Patel, Elspeth A Brzezinska, Peter Repiscak, et al.
Transplantation and Cellular Therapy|August 16, 2025
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT RegistrySandra Cohen, Myriam Labopin, Nadia Bambace, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
Therapeutic Advances in Medical Oncology|April 29, 2024
Treatment with nanosomal paclitaxel lipid suspension <i>versus</i> conventional paclitaxel in metastatic breast cancer patients - a multicenter, randomized, comparative, phase II/III clinical studyChiradoni Thungappa Satheesh, Rakesh Taran, Jitendra Kumar Singh, et al.
Hereditary Cancer in Clinical Practice|June 16, 2022
Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in PakistanFizza Akbar, Zahraa Siddiqui, Muhammad Talha Waheed, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
Oncogene|November 20, 2019
BRF1 accelerates prostate tumourigenesis and perturbs immune infiltrationCarolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, et al.
Oncogene|December 21, 2019
Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltrationCarolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, et al.
Pageof 45

Showing results (421-430 of 442) with videos related to

Sort By:
Pageof 45
European Urology Open Science|August 2, 2021
Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal MetastasisChara Ntala, Mark Salji, Jonathan Salmond, et al.
BJU International|December 8, 2021
Feasibility and safety of radical prostatectomy for oligo-metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo-Metastases to the bone (TRoMbone) trialPrasanna Sooriakumaran, Caroline Wilson, Ines Rombach, et al.
Cancer Research|November 14, 2019
Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate CancerRachana Patel, Elspeth A Brzezinska, Peter Repiscak, et al.
Transplantation and Cellular Therapy|August 16, 2025
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT RegistrySandra Cohen, Myriam Labopin, Nadia Bambace, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
Therapeutic Advances in Medical Oncology|April 29, 2024
Treatment with nanosomal paclitaxel lipid suspension <i>versus</i> conventional paclitaxel in metastatic breast cancer patients - a multicenter, randomized, comparative, phase II/III clinical studyChiradoni Thungappa Satheesh, Rakesh Taran, Jitendra Kumar Singh, et al.
Hereditary Cancer in Clinical Practice|June 16, 2022
Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in PakistanFizza Akbar, Zahraa Siddiqui, Muhammad Talha Waheed, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
Oncogene|November 20, 2019
BRF1 accelerates prostate tumourigenesis and perturbs immune infiltrationCarolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, et al.
Oncogene|December 21, 2019
Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltrationCarolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, et al.
Pageof 45